MPEP § 2415 — Applicability date of “Sequence Listing XML” Requirements to Applications Based on Filing Date of Application and Procedures for Failure to Submit Correct Format of Sequence Listing

Ninth Edition, Revision 01.2024 · last revised R-01.2024

[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]

Patent applications that contain disclosures of nucleotide and/or amino acid sequences must present the sequences and associated biological sequence data in a standardized electronic format. For those applications having a filing date on or after July 1, 2022, a “Sequence Listing XML” (see 37 CFR 1.831(a)) as a separate part of the specification is required. Note that for national phase applications submitted under 35 U.S.C. 371, the relevant date is the international filing date.